Horizons Global Solutions LLC

Horizons Global Solutions LLC filed a Q4 report for Captura Biopharma on January 8, 2026.

Lobbying for Captura Biopharma · Captura is developing an orally administered MCM for radionuclide contamination.

As filed: HORIZONS GLOBAL SOLUTIONS LLC for CAPTURA BIOPHARMA.

All filings by Horizons Global Solutions LLC · Everything Captura Biopharma has reported

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Feb 10, 2026.

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 8, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Arkansas

Official filing document

Lobbyists on this filing 3

DAVID FORREST LASSETER

Previously held: Schedule C (DoD and DOJ); Congressional Staffer (U.S. House and U.S. Senate)
JULIE LASSETER

Previously held: Schedule C (DoD); Congressional Staffer (U.S. House and U.S. Senate)
STEPHEN ELLIOTT BOYD New on this filing

Previously held: Assistant Attorney General at Department of Justice; former Congressional Aide (House and Senate).

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Defense

2026/2027 NDAA; FY2026/2027 Defense Appropriations

Disaster Planning/Emergencies

FY2026/2027 NDAA; FY2026/2027 Defense Appropriations

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.